UPDATE: Physiome Buys IBM s Power4-Based Supercomputer, Announces Research Pact | GenomeWeb

NEW YORK, Aug. 14 - IBM and Physiome Sciences have entered into a non-exclusive alliance that will combine IBM's supercomputing technology with Physiome’s biological modeling software, the companies announced.  

The deal, which makes IBM Physiome's preferred IT supplier for custom computing, will allow Physiome to “speed up” its ability to simulate models of various cells, tissues and organs, and affect the behavior of certain disease states. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: a sequencing-based screen of Lyme disease-causing pathogen, the range of animals bitten by Anopheles darling mosquitoes in Peru, and more.

An NC State researcher is exploring the use of CRISPR-Cas3 as an anti-microbial, Gizmodo reports.

The Earth BioGenome Project plans to sequence all life on Earth, according to ScienceInsider.

For those who are concerned about Trump administration actions related to science, a new column in Scientific American has suggestions for ways to fight back.